Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, Forouzanfar MH, Longenecker CT, Mayosi BM, Mensah GA et al (2017) Global, Regional, and National Burden of Rheumatic Heart Disease, 1990–2015. N Engl J Med 377:713–722. https://doi.org/10.1056/NEJMoa1603693
Zuhlke L, Karthikeyan G, Engel ME, Rangarajan S, Mackie P, Cupido-Katya Mauff B, Islam S, Daniels R, Francis V, Ogendo S et al (2016) Clinical outcomes in 3343 children and adults with Rheumatic Heart Disease from 14 low- and Middle-Income countries: two-year Follow-Up of the global Rheumatic Heart Disease Registry (the REMEDY Study). Circulation 134:1456–1466. https://doi.org/10.1161/CIRCULATIONAHA.116.024769
Saxena A (2013) Echocardiographic diagnosis of chronic rheumatic valvular lesions. Glob Heart 8:203–212. https://doi.org/10.1016/j.gheart.2013.08.007
Peters F, Karthikeyan G, Abrams J, Muhwava L, Zuhlke L (2020) Rheumatic heart disease: current status of diagnosis and therapy. Cardiovasc Diagn Ther 10:305–315. https://doi.org/10.21037/cdt.2019.10.07
Article PubMed PubMed Central Google Scholar
Manjunath C, Srinivas P, Ravindranath K, Dhanalakshmi C (2014) Incidence and patterns of valvular heart disease in a tertiary care high-volume cardiac center: a single center experience. Indian Heart J 66:320–326
Article CAS PubMed PubMed Central Google Scholar
Remenyi B, ElGuindy A, Smith SC Jr, Yacoub M, Holmes DR Jr (2016) Valvular aspects of rheumatic heart disease. Lancet 387:1335–1346
Gerçek M, Rudolph V (2021) Secondary tricuspid regurgitation: pathophysiology, incidence and prognosis. Front Cardiovasc Med. ;8. doi
Shiran A, Sagie A (2009) Tricuspid regurgitation in mitral valve disease: incidence, prognostic implications, mechanism, and management. J Am Coll Cardiol 53:401–408
Kelly BJ, Luxford JMH, Butler CG, Huang C-C, Wilusz K, Ejiofor JI, Rawn JD, Fox JA, Shernan SK, Muehlschlegel JD (2018) Severity of tricuspid regurgitation is associated with long-term mortality. J Thorac Cardiovasc Surg 155:1032–1038 e1032. doi:
Offen S, Playford D, Strange G, Stewart S, Celermajer DS (2022) Adverse prognostic impact of even mild or moderate tricuspid regurgitation: insights from the National Echocardiography Database of Australia. J Am Soc Echocardiogr 35:810–817. https://doi.org/10.1016/j.echo.2022.04.003
Benfari G, Antoine C, Miller WL, Thapa P, Topilsky Y, Rossi A, Michelena HI, Pislaru S, Enriquez-Sarano M (2019) Excess mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction. Circulation 140:196–206
Article CAS PubMed Google Scholar
Essayagh B, Antoine C, Benfari G, Maalouf J, Michelena HI, Crestanello JA, Thapa P, Avierinos JF, Enriquez-Sarano M (2020) Functional tricuspid regurgitation of degenerative mitral valve disease: a crucial determinant of survival. Eur Heart J 41:1918–1929. https://doi.org/10.1093/eurheartj/ehaa192
Bannehr M, Edlinger CR, Kahn U, Liebchen J, Okamoto M, Hahnel V, Dworok V, Schipmann F, Kucken T, Bramlage K et al (2021) Natural course of tricuspid regurgitation and prognostic implications. Open Heart 8. https://doi.org/10.1136/openhrt-2020-001529
Song H, Kim M-J, Chung CH, Choo SJ, Song MG, Song J-M, Kang D-H, Lee JW, Song J-K (2009) Factors associated with development of late significant tricuspid regurgitation after successful left-sided valve surgery. Heart 95:931–936
Article CAS PubMed Google Scholar
Nunes MCP, Tan TC, Elmariah S, Lodi-Junqueira L, Nascimento BR, do Lago R, da Silva JLP, Reis RCP, Zeng X, Palacios IF (2017) Net atrioventricular compliance is an independent predictor of cardiovascular death in mitral stenosis. Heart 103:1891–1898
Article CAS PubMed Google Scholar
Lee S-P, Kim H-K, Kim K-H, Kim J-H, Park HE, Kim Y-J, Cho G-Y, Sohn D-W (2013) Prevalence of significant tricuspid regurgitation in patients with successful percutaneous mitral valvuloplasty for mitral stenosis: results from 12 years’ follow-up of one centre prospective registry. Heart 99:91–97
Sagie A, Schwammenthal E, Newell JB, Harrell L, Joziatis TB, Weyman AE, Levine RA, Palacios IF (1994) Significant tricuspid regurgitation is a marker for adverse outcome in patients undergoing percutaneous ballon mitral valvuloplasty. J Am Coll Cardiol 24:696–702
Article CAS PubMed Google Scholar
Sultan F, Moustafa SE, Tajik J, Warsame T, Emani U, Alharthi M, Mookadam F (2010) Rheumatic tricuspid valve disease: an evidence-based systematic overview. J Heart Valve Dis 19:374–382
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart Journal-Cardiovascular Imaging 16:233–271
Diamond A, Sekhon JS (2013) Genetic matching for estimating Causal effects: a General Multivariate Matching Method for Achieving Balance in Observational studies. Rev Econ Stat 95:932–945. https://doi.org/10.1162/REST_a_00318
Badano LP, Hahn R, Rodriguez-Zanella H, Araiza Garaygordobil D, Ochoa-Jimenez RC, Muraru D (2019) Morphological Assessment of the tricuspid apparatus and grading regurgitation severity in patients with functional tricuspid regurgitation: thinking outside the Box. JACC Cardiovasc Imaging 12:652–664. https://doi.org/10.1016/j.jcmg.2018.09.029
Goswami KC, Rao MB, Dev V, Shrivastava S (1999) Juvenile tricuspid stenosis and rheumatic tricuspid valve disease: an echocardiographic study. Int J Cardiol 72:83–86
Article CAS PubMed Google Scholar
Singulane CC, Singh A, Addetia K, Yamat M, Lang RM (2022) Developing insights regarding tricuspid valve regurgitation: morphology, Assessment of Severity, and the need for a Novel Grading Scheme. Struct Heart 6:100026. https://doi.org/10.1016/j.shj.2022.100026
Comments (0)